Ten National and Regional Ontario Genomics Projects are Part of $20 Million Funding Package

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Ten new Ontario Genomics projects are part of the Canadian government’s $20 million investment in 34 biotech R&D commercialization initiatives across the country. Stemming from the Canadian Genomics Strategy, these national and regional Genomic Applications Partnership Program (GAPP) projects are advancing precision healthcare, cleantech and food safety in a variety of ways.

Congratulations to the four OBIO-affiliated companies; Neuropeutics, PhenoTips, ProteinQure, and SpecificBiologics selected among the Ontario Genomics projects.

Read more
Arsheen Kaur
Next

Merck Digital Sciences Studio Expands with Second Innovation Class to Advance Biopharma and Digital Health Progress in North America